MAP2K5 (mitogen-activated protein kinase kinase 5, also known as MEK5) has been associated with various diseases including cardiovascular diseases, cancers, and central nervous system disorders (Appari et al., 2017; Liu et al., 2017; Castro et al., 2019). Here, MAP2K5 is linked to central nervous system disorder.